Back to Search
LAURA LEBEL, MD
MD
Obstetrics & Gynecology Physician
NPI: 1972694016IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
23313(SC)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Class of 1997
Research & Publications (20)
Industrial transformation and shrimp aquaculture in Thailand and Vietnam: pathways to ecological, social, and economic sustainability?
PMID 12174602·Ambio·2002
7-preclinical
Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists.
PMID 19576766·Bioorg Med Chem Lett·2009
7-preclinical
The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter.
PMID 19410451·Bioorg Med Chem Lett·2009
8-other
The age of red blood cells in premature infants (ARIPI) randomized controlled trial: study design.
PMID 19056034·Transfus Med Rev·2009
4-observational
Quantitative structure-activity relationship of phenoxyphenyl-methanamine compounds with 5HT2A, SERT, and hERG activities.
PMID 18948001·Bioorg Med Chem Lett·2008
8-other
Deconstructing cytisine: The syntheses of (+/-)-cyfusine and (+/-)-cyclopropylcyfusine, fused ring analogs of cytisine.
PMID 18356044·Bioorg Med Chem Lett·2008
8-other
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia.
PMID 18287214·J Pharmacol Exp Ther·2008
7-preclinical
A novel, non-substrate-based series of glycine type 1 transporter inhibitors derived from high-throughput screening.
PMID 17257843·Bioorg Med Chem Lett·2007
8-other
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitors.
PMID 17228859·J Med Chem·2007
7-preclinical
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
PMID 17157884·Neuropharmacology·2007
7-preclinical
Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
PMID 16780899·Neuropharmacology·2006
7-preclinical
3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation.
PMID 16171993·Bioorg Med Chem Lett·2005
7-preclinical
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
PMID 15908213·Bioorg Med Chem Lett·2005
7-preclinical
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
PMID 15887955·J Med Chem·2005
7-preclinical
Antibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancer.
PMID 15623612·Clin Cancer Res·2004
4-observational
[3H]-(R)-NPTS, a radioligand for the type 1 glycine transporter.
PMID 12657266·Bioorg Med Chem Lett·2003
7-preclinical
Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum.
PMID 12554681·Hum Mol Genet·2003
7-preclinical
Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth.
PMID 12374761·Hum Mol Genet·2002
7-preclinical
Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice.
PMID 12217951·Hum Mol Genet·2002
7-preclinical
Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice.
PMID 11912178·Hum Mol Genet·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 801 ROPER CREEK DRIVE
GREENVILLE, SC 29615 - Phone
- (864) 343-3553
Quick Facts
- NPI
- 1972694016
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile